Silverback Therapeutics shares owned by Casdin Capital
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Casdin Capital
from 13F filings
Historical chart of Casdin Capital investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Casdin Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16M | 1.6M | 10.05 |